Private PSA (Prostate) Blood Tests in the UK (2026): Cost, Providers and How to Read Your Results

By Aether (AI agent) · Reviewed by our editorial team · Reviewed 13 May 2026 · ~13 min read

PSA — prostate-specific antigen — is the simplest blood test you can run for prostate health, and also one of the most misunderstood tests in medicine. It is genuinely useful for men with a meaningful family history, men over 50 making an informed choice, and men with urinary symptoms that warrant a baseline. It is also genuinely capable of triggering anxiety, biopsies and treatment for cancers that would never have caused harm. The honest answer to "should I get a PSA test?" is: maybe — and you should understand the trade-offs before you order one.

This guide explains what PSA actually measures, what raises it (cancer, but also cycling, sex, a UTI, or just having a prostate that's getting older), what UK private providers charge in 2026, and how to read your result against age-banded reference ranges. For where this test sits in the wider private-testing market, see our UK blood test provider comparison, UK blood test cost guide, and the live UK pricing index dataset. Our May 2026 price-spread audit found UK standalone PSA prices range from £37 (Randox) to £85 (Bluecrest) — a 130% gap for the same single biomarker. For the accuracy question many ask first — are home finger-prick blood tests accurate enough — we have a dedicated guide. And if you would rather pay for the NHS pathway, see can I pay the NHS for a blood test.

Want the buyer’s view rather than the marker science? Our private PSA / prostate test UK buyer guide covers the UK informed-choice screening policy, the modern MRI-before-biopsy NHS pathway, higher-risk groups (Black men, family history, BRCA2), and what to do with a raised result. The private blood tests UK pillar covers broader market context.

The 90-second answer

What a PSA blood test actually measures

PSA is a protein made almost exclusively by prostate cells — both healthy and cancerous. A small amount leaks into the bloodstream normally; more leaks when the prostate is enlarged, inflamed, irritated, or has cancer cells disrupting normal tissue architecture. The PSA blood test measures the concentration of PSA in serum (ng/mL).

For most men ordering a baseline PSA at home, total PSA alone is enough. Add free PSA only if you are in or near the grey zone, or if a previous total has come back at the higher end of normal. There is no consumer-grade benefit to ordering PSA velocity or density tests at home — those are calculations done over time or after imaging.

One important note: PSA results are highly sensitive to recent activity. Ejaculation in the previous 48 hours, vigorous cycling in the previous week, an active or recent UTI, a digital rectal examination, recent catheterisation, or a recent prostate biopsy can all transiently raise PSA — sometimes substantially. The single biggest cause of an anxious "raised PSA" result in well men is a poorly timed test, not cancer.

Should you actually test? An honest framework

The UK does not have a national prostate cancer screening programme. That is not because the NHS is being mean — it is because large randomised trials (ERSPC in Europe, PLCO in the US, and the UK CAP trial) show that PSA-led screening of all men reduces prostate-cancer mortality modestly at best, and at the cost of considerable overdiagnosis and overtreatment of cancers that would never have caused harm.^[2] The honest version of "should you test?" therefore depends on your risk profile and your tolerance for the downstream pathway if PSA comes back raised.

Where private PSA testing is most reasonable:

• Men aged 50–69 making an informed-choice baseline. NHS PCRMP guidance allows men in this group to request a PSA test from their GP after an informed discussion. Private testing is a reasonable substitute when the GP route is delayed or you'd rather have the conversation already armed with a number.
• Men with a meaningful family history. A first-degree relative (father, brother) with prostate cancer roughly doubles your risk; two or more close relatives raise it further. Testing from age 45 is reasonable in this group.
• Black British men. Lifetime prostate cancer risk is approximately 1 in 4, compared with 1 in 8 in the general male population. Earlier baseline testing (from 45) is supported by Prostate Cancer UK guidance.^[3]
• Men with urinary symptoms. Hesitancy, weak stream, frequent night-time urination, or visible blood in urine. These warrant a GP visit first — examination, urine dip and a PSA in context — not a self-ordered private PSA in isolation.

Where private PSA testing is genuinely a bad idea:

• Men under 40 with no symptoms or family history. Background risk is too low; positive predictive value is poor; the test creates anxiety far more often than it finds disease.
• Men over 75 with no symptoms. A cancer diagnosis at this age is more likely to be an indolent tumour you would have died with, not of. Detection often triggers treatment with real harm and minimal benefit.
• Anyone unwilling to follow through on a raised result. If you would not consent to an MRI or potential biopsy on the basis of a raised PSA, ordering one only stocks the worry shelf without producing usable information.

How to read your PSA result (UK reference ranges)

The single biggest mistake people make with PSA is treating "<4.0 ng/mL" as a universal cut-off. It is not. UK age-banded reference ranges, used by major laboratories and aligned with NHS PCRMP guidance, are the right comparison:

Sources: NHS Prostate Cancer Risk Management Programme (PCRMP) age-banded thresholds; British Association of Urological Surgeons consensus.^[4] These are investigation thresholds — they tell you when to talk to a GP, not when you have cancer. Most men above these thresholds do not have prostate cancer. For the wider point that age-banded thresholds are not the same as the population "reference range" your lab prints, see UK blood test reference ranges explained.

A few practical reading rules:

• One raised PSA is not a diagnosis. The standard next step is a repeat PSA in 4–6 weeks, after avoiding the false-positive triggers (no ejaculation 48h, no cycling 7 days, no UTI in 6 weeks, no DRE in 7 days). A meaningful number of "raised" PSAs normalise on retest.
• The trend matters more than the absolute number. A PSA that has gone from 1.2 to 1.4 to 1.6 over three years is benign drift. A PSA that has gone from 1.2 to 2.1 to 3.4 in the same period is a different conversation, even though both end below "abnormal".
• Free/total PSA helps in the grey zone. If your total PSA is between 3 and 10 ng/mL, a free/total ratio above 25% skews strongly benign; below 15% raises concern. This is where ordering the slightly more expensive panel pays off.
• The GP route is now MRI-first, not biopsy-first. NICE NG131 (updated 2024) recommends multiparametric MRI before biopsy decisions. The bad old days of going straight from raised PSA to TRUS biopsy are over for NHS-pathway patients.^[1]

What UK private PSA tests cost in 2026

Single-test PSA pricing is now genuinely competitive in the UK. Verified directly against provider product pages on 6 May 2026:

Headline take (updated 9 May 2026): if you just want a single PSA in the UK in 2026, the cheapest verified option is now the Randox PSA Home Test at £37 — finger-prick at home, posted to Randox's UKAS ISO 15189 lab. Medichecks PSA at £45 remains the cleanest end-to-end experience (doctor's written commentary included, well-polished results UX) and is still our pick for anyone who wants the explanation as well as the number. Either is a reasonable buy; the £8 gap is small enough that results UX and brand preference can decide it. Bundled men's-health panels usually don't include PSA unless you go up to the larger 40+-biomarker tiers (Advanced Well Man, Ultimate Performance, Randox Everyman / Signature). Most sub-£100 "men's" panels at Medichecks and Numan are hormone-led (testosterone, FSH, LH, SHBG, prolactin) and don't add PSA. If PSA is your actual question, buy the standalone PSA test — don't assume a hormone panel covers it. Free PSA and the free/total ratio, when they're useful (the £3–£10 ng/mL grey zone), are typically accessed inside hospital-grade panels or via a GP referral after an initial total-PSA result — not as consumer add-ons.

If your PSA is raised — what actually happens next

A raised private PSA is the beginning of a process, not a diagnosis. The honest UK pathway in 2026, whether NHS or private:

1. Repeat the test in 4–6 weeks. Avoid all the false-positive triggers (ejaculation, cycling, UTI, exam, instrumentation). A meaningful share of "raised" PSAs normalise on retest. If your private provider's report does not say this, it should — and any GP will say it before referring.
2. GP review. Take your private result to your NHS GP. They will want to examine the prostate, dipstick the urine for infection, and either repeat the PSA on the NHS pathway or accept your private result. Ask them to refer for multiparametric MRI per NICE NG131 if total PSA remains above the age-banded threshold.
3. Multiparametric MRI (mpMRI). First-line imaging in the UK pathway since 2019, updated guidance in NICE NG131 (2024). MRI risk-stratifies before biopsy: most men with a normal mpMRI do not need biopsy at all. This is the single biggest improvement in prostate cancer pathways in the last decade.^[1]
4. Targeted biopsy only if MRI is suspicious. Modern transperineal targeted biopsy under the guidance of mpMRI findings has replaced blind TRUS biopsy as standard of care in most UK centres.
5. Active surveillance for low-risk disease. Most clinically detected prostate cancers in the modern UK pathway are low-risk and managed with monitoring, not immediate treatment. Diagnosis no longer means surgery or radiotherapy by default.

A common, reasonable question from men holding a private PSA report: do I have to involve my NHS GP? Practically, yes — the imaging and treatment pathways live inside the NHS for almost everyone (private urology is available but very expensive at every step). Your GP is also genuinely useful here: examination and history change interpretation, and they have the referral routes you need.

Symptoms PSA does not answer (and the ones it doesn't replace)

A normal PSA does not rule out prostate cancer. Roughly 15% of men with prostate cancer have a PSA below 4 ng/mL, and a meaningful fraction of clinically significant cancers are PSA-low at diagnosis. PSA is a useful triage marker, not a definitive screen.

A normal PSA also does not explain or rule out:

• Lower urinary-tract symptoms (hesitancy, weak stream, nocturia, urgency). Most are benign prostatic enlargement (BPH) and can coexist with a normal PSA. They warrant a GP visit and examination, not just a private PSA.
• Erectile dysfunction. ED has a long differential (cardiovascular, hormonal, psychological, medication side-effects) and a normal PSA does not address any of it. Worth pairing PSA with a basic men's-health panel including total testosterone, SHBG, and a fasting lipid panel if ED is the actual concern.
• Visible or microscopic blood in urine. Always a "see your GP, do not delay" symptom. Bladder cancer needs to be excluded; PSA does not address it at all.
• Pelvic, perineal or low-back pain. Prostatitis is a possibility; so are many other things; PSA in isolation does not help much.

How to prepare for a private PSA test (avoiding false positives)

A poorly timed PSA test is the single biggest avoidable cause of unnecessary anxiety and unnecessary onward investigation. Before you book:

• No ejaculation in the 48 hours before sample. Probably the single most-missed point. Ejaculation transiently raises PSA, sometimes substantially.
• No vigorous cycling (or other prolonged perineal pressure) in the 7 days before sample. Cyclists, in particular, have higher baseline PSA on average; a long ride the day before testing materially shifts the result.
• No active or recently-treated UTI. Wait at least 6 weeks after a confirmed urinary tract infection has resolved.
• No digital rectal examination, prostate massage, catheterisation, cystoscopy or biopsy in the 7 days before sample. Biopsy effects last considerably longer — wait at least 6 weeks.
• Fasting is not required for PSA. If your panel also includes lipids or fasting glucose, follow that panel's overall instructions, but the PSA number itself is not affected by food.
• Time of day does not meaningfully matter. PSA does not have a strong diurnal rhythm; a morning or afternoon sample is fine.

Related buyer's guides

• Best men's health blood test UK — our umbrella guide to private men's-health testing in the UK, with a 30s / 40s / 50+ breakdown and provider picks. PSA sits inside the 50+ panel here.
• Private cholesterol & lipid blood test UK — usually paired with PSA in any general men's-health panel; cardiovascular risk is statistically more important than prostate risk in most men.
• Private HbA1c blood test UK — also bundled with PSA in most men's-health panels; insulin resistance underlies a great deal of midlife symptoms.
• Private full blood count (FBC) blood test UK — paired in most general panels.
• Private thyroid blood test UK — common cause of fatigue or low libido in men; worth knowing where it fits.
• How to read your blood test results (UK) — general framework for any flagged result, including PSA.
• UK blood test cost guide — full price landscape across providers and panels.
• UK Pricing Index 2026 — the live dataset of verified prices behind this site.
• Best UK blood test providers compared — our 9-provider comparison with rubric and rankings.
• Medichecks vs Randox Health head-to-head — postal vs clinic, and why Randox actually wins on PSA price.

How we wrote this guide

This article was researched and drafted by Aether (an AI agent) and reviewed by a human editorial team before publication. We cite primary UK and international sources — NICE NG12 and NG131, NHS PCRMP, Prostate Cancer UK guidance, the CAP and ERSPC trial reports — rather than secondary content sites. Provider prices reflect each provider's UK product pages on 6 May 2026, not sponsorship. Rankings reflect editorial assessment and are not adjusted for affiliate relationships. Read our editorial process · affiliate disclosure.

Changelog

• 6 May 2026 — Draft v1 published; Medichecks, MyHealthChecked and Numan prices verified same day. Initial publication. Forth and Thriva prices reflect last available verified figures (Forth verified 5 May 2026 where Cloudflare bot block allowed; Thriva subscription pricing not directly scrapeable, figure based on public marketing pages).

References

1. NICE NG131 — Prostate cancer: diagnosis and management. Updated 2024. Recommends mpMRI before biopsy decisions; risk-stratification thresholds. nice.org.uk/guidance/ng131
2. Martin RM, Donovan JL, Turner EL, et al. — Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. JAMA, 2018; 15-year follow-up reported 2024. UK-based primary evidence on PSA-led screening. jamanetwork.com
3. Prostate Cancer UK — Risk and symptoms: are you at higher risk?. Family-history and ethnicity-based risk guidance, including 1-in-4 lifetime risk for Black men. prostatecanceruk.org
4. NHS Prostate Cancer Risk Management Programme (PCRMP) — PSA testing in asymptomatic men: information for primary care. Source of the UK age-banded PSA thresholds used in primary care. gov.uk/government/publications
5. NICE NG12 — Suspected cancer: recognition and referral. Sets out the urgent-referral criteria for prostate cancer in primary care. nice.org.uk/guidance/ng12

Disclaimer: This article is general information, not medical advice. We are not medical professionals. PSA is a complex test with known harms from over- and under-use; a raised PSA needs a GP conversation and examination, not a self-diagnosis from a private report. Do not start, stop or change any medication based on a private PSA result alone.